MHRA Cuts Nasal Decongestant Spray Limit to 5 Days

The MHRA has cut the recommended use of xylometazoline and oxymetazoline nasal sprays to five days over rebound congestion risks.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/mhra-cuts-nasal-decongestant-spray-limit-five-days-2026a1000dzj?src=rss

Author :

Publish date : 2026-05-01 16:56:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

MHRA Cuts Nasal Decongestant Spray Limit to 5 Days

‘I was slowly slipping into insanity because of PMDD’

Are Food Allergies Overdiagnosed in Black Patients?

Related Posts

FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation

Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps

US Court Blocks Mail-order Access to Abortion Drugs, for Now

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation

Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps

US Court Blocks Mail-order Access to Abortion Drugs, for Now

Study Examines if Prenatal Exposure to Sedatives Is Linked to Psych Disorders

FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

As RFK Jr. Downplays Rabies, CDC Staff Tells Docs It’s a Daily Threat

Which Former NIH Official Was Indicted?

Categories

Archives